TABLE 1.
5′ to 3′ sequencea | ORFb | REc | Locationd | Directione | Clonef |
---|---|---|---|---|---|
CGTCGAGCTC ATG GAA GAA CCA ATT TGT | 21 | SacI | 30,759 | Forward | 21A, 21A1, 21A+B |
CTCAGCGGCCGC CAT TCC AAT ACG AGC GTG AGT GAA TGG | 21 | NotI | 31,286 | Reverse | 21A1 |
CGTCGAGCTC CCA TTC ACT CAC GCT CGT ATT GGT ATG | 21 | SacI | 31,260 | Forward | 21A2 |
CTCAGCGGCCGC ACG GGT GTG TTC TGC TAC | 21 | NotI | 31,826 | Reverse | 21A, 21A2 |
CGTCGAGCTC GTA GCA GAA CAC ACC CGT | 21 | SacI | 31,809 | Forward | 21B |
CTCAGCGGCCGC GAG AGT TGC TAA AAA AAC | 21 | NotI | 32,909 | Reverse | 21B |
CGTCGAGCTC GTT TTT TTA GCA ACT CTC | 21 | SacI | 32,892 | Forward | 21C |
CTCAGCGGCCGC TTA AGG GTC ACT CCC ACT TGT | 21 | NotI | 33,875 | Reverse | 21C |
CGTCGAGCTC ATG GAA ATT ACT CAG AAG | 29 | SacI | 50,857 | Forward | 29A |
CTCAGCGGCCGC CGC CAG GCC TAT AAA CAT | 29 | NotI | 51,924 | Reverse | 29A |
CGTCGAGCTC ATG TTT ATA GGC ATG GAG | 29 | SacI | 51,907 | Forward | 29B |
ACTCGCGGCCGC CCT ATA AGT GTC CTG CAT | 29 | NotI | 52,581 | Reverse | 29B |
CGTCGAGCTC ATG CAG GAC ACT TAT AGG | 29 | SacI | 52,564 | Forward | 29C |
CTCAGCGGCCGC GGA TTT ACT GTT TGG TGG CAT | 29 | NotI | 53,361 | Reverse | 29C |
CTGTCGAGCTC ATG CCA CCA AAC AGT AAA TCC | 29 | SacI | 53,341 | Forward | 29D |
CTCAGCGGCCGC ATT TCC CGA CGA GGG ACC | 29 | NotI | 53,991 | Reverse | 29D |
CGTCGAGCTC GGT CCC TCG TCG GGA AAT | 29 | SacI | 53,974 | Forward | 29E |
CTCAGCGGCCGC TTA AAT CAT TTC CAT TGT AAT | 29 | NotI | 54,471 | Reverse | 29E |
Oligonucleotide sequences including leader (single underline) and restriction endonuclease (double underline) sites 5′ with respect to the VZV DNA sequence.
VZV open reading frames.
Restriction endonuclease (RE) sites used for cloning.
Locations on the VZV genome of the 5′ nucleotide.
Directions (5′ to 3′) with respect to ORF.
PCR fragment identifications (see also Fig. 6).